DelveInsight's "Psychosis Market Insights, Epidemiology, and Market Forecast 2030" reports deliver an in-depth understanding of the disease, historical and forecasted epidemiology, the pipeline insight as well as the Psychosis market size and shares analysis in the seven major markets (7MM).
The report also covers emerging drugs, current treatment practices, Psychosis Market Shares of the individual therapies, a detailed current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assess the underlying potential of the market.
The report analyses the Psychosis Market trends and developments in the seven major markets (i.e. the United States, Germany, France, Italy, Spain, the United Kingdom, and Japan.
Psychosis is characterized by an impaired association with reality. Psychosis is a symptom and not an illness. It is a symptom of serious mental disorders. A mental or physical illness, substance abuse, or extreme stress or trauma can cause it. Psychosis can also be a symptom of a mental illness, like schizophrenia or bipolar disorder.
Psychosis can affect people from all walks of life. Psychosis often begins when a person is in his or her late teens to mid-twenties. There are about 100,000 new cases of psychosis each year in the U.S. As many as 3 in 100 people will have an episode at some point in their lives.
Psychotic disorders are severe mental disorders that cause abnormal thinking and perceptions. People with Psychosis lose touch with reality. Two of the main symptoms are delusions and hallucinations. Traditional treatment for Psychosis involves psychotherapy, cognitive-behavioral therapy (CBT), Art therapy, and medication like Antipsychotic medication.
Psychosis Market Key Facts
- Psychotic disorders are associated with substantial premature mortality, morbidity, and a large social and financial burden. People with severe mental illness (SMI), such as psychosis are at increased risk of poor physical health and die on average 15 to 20 years earlier than the general population.
- It was estimated that the cumulative incidence of psychotic symptoms in older adults has been found to be 6% with a follow-up duration of 3.6 years, 8% with a follow-up duration of 7 years, and 4.8% among 70-year-olds followed until death or age 90.
Psychosis Market Size
The Psychosis market size shall grow during the forecast period owing to the launch of upcoming therapies, increased patient pool, and the rise in healthcare spending across the world.
The Psychosis market analysis section of the report helps to understand the current and forecasted Psychosis Market Trends and Growth by evaluating the impact of current therapies on the market, unmet needs, drivers, and barriers. The report gives complete detail of Psychosis Market Size and Shares of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Currently, Psychosis is at the forefront of biomedical research. Researchers are working to uncover as many aspects of the illness and related possible causes as possible. Many potential approaches are currently under investigation worldwide. Researchers hope to develop therapies targeting specific genetic, molecular, and cellular mechanisms so that the actual underlying cause of the illness can be stopped or prevented.
Some of the key Companies in the Psychosis Market include NeuroRx, Sunovion, SAGE Therapeutics, Karuna Therapeutics, Intra-Cellular Therapies, and many others. Psychosis Therapies covered in the report include ITI-333, KarXT, Zuranolone, SEP-363856, Cycloserine/lurasidone, and many more.
Psychosis Epidemiology Forecast
Psychosis Epidemiology Segmentation
- Total Prevalent Cases of Psychosis
- Gender-specific Prevalent Cases of Psychosis
- Age-specific Prevalent Cases of Psychosis
- Diagnosed and Treatable Cases of Psychosis
The epidemiology section covers detailed insights about the patient pool for every seven major countries. It helps to recognize the causes of current and forecasted Psychosis Epidemiology Trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends, along with assumptions undertaken.
For more details, visit: Psychosis Market Size